Long‐read sequencing reveals genomic and epigenomic variation in the dark genome of human Alzheimer's disease
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70852 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Paulino Ramirez und 8 weiteren Autor:innen. Beteiligte Einrichtung: Barshop Institute for Longevity and Aging Studies, San Antonio, Texas, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Epigenesis, Genetic. Die Arbeit nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BrightFocus Foundation, NIA NIH HHS, NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Faulty DNA repair and epigenetic regulation contribute to neurodegeneration in Alzheimer's disease. Long‐read sequencing enables analysis of “dark regions” that are difficult to study via traditional sequencing methodologies. METHODS Using nanopore whole‐genome DNA sequencing of post mortem brain from early‐ and late‐ stage Alzheimer's disease cases and controls, we analyzed retrotransposition, non‐allelic homologous recombination (NAHR), structural variation, and DNA methylation within repetitive regions. RESULTS Retrotransposon insertions and NAHR were enriched in centromeric/pericentromeric and ribosomal DNA (rDNA) in the aged brain. Putatively somatic AluY retrotransposon insertions trended upward in late‐stage disease. Enrichment of NAHR between repetitive regions and DNA demethylation were detected in early disease. Differential methylation of dark regions within specific Alzheimer's disease risk genes and repetitive elements occurred across disease stage. DISCUSSION This study provides the first long‐read analysis of repetitive elements in the aged human brain and identifies these regions as hotspots for genomic variation in Alzheimer's disease. Highlights Long‐read sequencing enables analysis of “dark” regions Alzheimer's disease brains Somatic AluY retrotransposon insertions may be elevated in late‐stage disease Retrotransposon‐associated non‐allelic homologous recombination (NAHR) is enriched in repetitive regions in early disease DNA demethylation within the centro/pericentromere and ribosomal DNA (rDNA) occur across disease stage Dark regions of risk genes are differentially methylated across disease stage
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Barshop Institute for Longevity and Aging Studies, San Antonio, Texas, USA.
- Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, San Antonio, Texas, USA.
- Department of Cell Systems and Anatomy, University of Texas Health San Antonio, San Antonio, Texas, USA.
- Center for Alzheimer's Disease Research, Brown University, Providence, Rhode Island, USA.
- Clinical Neuroscience Research Center, Department of Neurosurgery, School of Medicine, Tulane University, New Orleans, Louisiana, USA.
- Laboratory for Transcriptome Technology, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.
Förderung
- BrightFocus Foundation
- NIA NIH HHS
- NIH HHS
- NINDS NIH HHS
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- National Institute of Neurological Disorders and Stroke
- National Institute on Aging
Zitieren
APA
Ramirez, P., Sun, W., Dehkordi, S. K., Zare, H., Pascarella, G., Carninci, P., Fongang, B., Bieniek, K. F., & Frost, B. (2025). Long‐read sequencing reveals genomic and epigenomic variation in the dark genome of human Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70852
Vancouver
Ramirez P, Sun W, Dehkordi SK, Zare H, Pascarella G, Carninci P, et al. Long‐read sequencing reveals genomic and epigenomic variation in the dark genome of human Alzheimer's disease. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70852
BibTeX
@article{Ramirez2025,
author = {Ramirez, Paulino and Sun, Wenyan and Dehkordi, Shiva Kazempour and Zare, Habil and Pascarella, Giovanni and Carninci, Piero and Fongang, Bernard and Bieniek, Kevin F and Frost, Bess},
title = {Long‐read sequencing reveals genomic and epigenomic variation in the dark genome of human Alzheimer's disease},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70852}
}
EUVIMED